As of Feb 22
| -0.10 / -1.96%|
The 9 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 10.00, with a high estimate of 28.00 and a low estimate of 6.00. The median estimate represents a +99.60% increase from the last price of 5.01.
The current consensus among 9 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.